Correlation Between Tscan Therapeutics and PennantPark Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and PennantPark Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and PennantPark Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and PennantPark Investment, you can compare the effects of market volatilities on Tscan Therapeutics and PennantPark Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of PennantPark Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and PennantPark Investment.

Diversification Opportunities for Tscan Therapeutics and PennantPark Investment

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Tscan and PennantPark is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and PennantPark Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PennantPark Investment and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with PennantPark Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PennantPark Investment has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and PennantPark Investment go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and PennantPark Investment

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the PennantPark Investment. In addition to that, Tscan Therapeutics is 3.81 times more volatile than PennantPark Investment. It trades about -0.23 of its total potential returns per unit of risk. PennantPark Investment is currently generating about 0.38 per unit of volatility. If you would invest  678.00  in PennantPark Investment on November 18, 2024 and sell it today you would earn a total of  44.00  from holding PennantPark Investment or generate 6.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Tscan Therapeutics  vs.  PennantPark Investment

 Performance 
       Timeline  
Tscan Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
PennantPark Investment 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in PennantPark Investment are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, PennantPark Investment is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Tscan Therapeutics and PennantPark Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tscan Therapeutics and PennantPark Investment

The main advantage of trading using opposite Tscan Therapeutics and PennantPark Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, PennantPark Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PennantPark Investment will offset losses from the drop in PennantPark Investment's long position.
The idea behind Tscan Therapeutics and PennantPark Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk